New daily pill can lead to significant weight loss
新的每日药可以帮助肥胖者减轻体重，而无需注射。该药物称为Orforglipron，是一种每天一次的片剂，属于一组称为GLP-1受体激动剂的药物。这些药物可以帮助人们感到饱满并减少食欲，并且它们已经用于[…]新的每日药可以导致大量体重减轻，首先是Knowridge Science报告。
A pill instead of an injection? New GLP-1 pill shows promising results in diabetes
一种新药，可以作为药丸，并且与Ozempic相同的药物，在临床试验中显示出对血糖控制的希望。该药物是Orforglipron，是一种胰高血糖素样肽-1（GLP-1）受体激动剂，在40周内显示出血糖控制的显着和临床有意义的改善，并使体重降低了7.6％。作者说，对血糖的影响的大小与先前的口服和可注射GLP-1受体激动剂试验的结果一致。
Lilly's Weight-Loss Pill Data Achieves "Best-Case Scenario", Sending Rival Novo Shares Into Abyss
Lilly's Weight-Loss Pill Data Achieves "Best-Case Scenario", Sending Rival Novo Shares Into AbyssEli Lilly shares surged 16% in late afternoon trading—marking their largest intraday gain since August 2023—after the pharmaceutical giant announced earlier that its new weight-loss pill met efficacy goa
